GPT Healthcare Embarks Its IPO Today: Details, GMP, Review, Should Apply?

The Initial Public Offering (IPO), which kicked off on February 22, 2024, is poised to remain open for bidders until February 26, 2024, offering investors a strategic window to partake in this transformative venture. Pioneering a book-build issue, GPT Healthcare Ltd. aims to raise a substantial amount, with the price band set between Rs 177 and Rs 186 per equity share. The offering encompasses a total issue size of 28,233,323 shares, amounting to an aggregate value of Rs 525.14 crore.

Towards a Transformative Future

As GPT Healthcare Ltd ventures into the public domain, it heralds a new chapter of growth, innovation, and value creation. With a steadfast commitment to delivering quality healthcare services and leveraging technological advancements, the company is poised to redefine the healthcare landscape, setting new benchmarks for excellence and patient-centric care. As the IPO progresses towards its culmination, anticipation mounts for the listing on both the BSE and NSE, scheduled for Thursday, February 29, 2024, marking a significant milestone in GPT Healthcare Ltd's journey towards sustained success and societal impact.

Strategic Allocation and Offer Dynamics

Ahead of its public offering, GPT Healthcare Ltd. has already garnered considerable interest from anchor investors, securing Rs 157.54 crore in investments. This solidifies the confidence of institutional stakeholders in the company's growth trajectory and underscores the robust potential inherent in its expansion plans. The IPO comprises a combination of fresh issue and offer for sale, with 0.22 crore shares allocated for fresh issue, aggregating to Rs 40.00 crores, and 2.61 crore shares earmarked for offer for sale, amounting to Rs 485.14 crores.

GPT Healthcare IPO GMP Status: Neutral

Market observers report that GPT Healthcare shares are trading in the grey market without any premium or discount.

Navigating Investment Parameters

For prospective investors, the IPO presents an opportunity to participate in the healthcare sector's growth story, with a minimum lot size set at 80 shares. Retail investors, with a minimum investment requirement of Rs 14,880, can actively engage in this offering, aligning their portfolios with a promising venture poised for expansion and innovation. Similarly, non-institutional investors have the option to invest in larger lot sizes, with sNII requiring 14 lots (1,120 shares) and bNII necessitating 68 lots (5,440 shares).

Stewarding the IPO Journey

Jm Financial Limited assumes the pivotal role of book runner and lead manager for the GPT Healthcare Ltd. IPO, orchestrating a seamless process of subscription and allocation. Backed by their expertise and market acumen, investors can navigate the complexities of the IPO landscape with confidence, leveraging strategic insights and advisory services. Furthermore, Link In time India Private Ltd. has been appointed as the registrar for the issue, ensuring meticulous oversight and compliance throughout the IPO journey.

GPT Healthcare

GPT Healthcare Ltd., a prominent player in the healthcare sector, has set the stage for its much-anticipated initial public offering (IPO) in the Indian primary market. With a legacy dating back to its inception in 1989, the company has emerged as a frontrunner in delivering comprehensive healthcare solutions, particularly in the eastern region of India. Under the esteemed brand banner of ILS Hospitals, GPT Healthcare Ltd. operates a network of mid-sized, multi-specialty hospitals, catering to a wide spectrum of medical needs with a strong emphasis on secondary and tertiary care services.